Assura Plc Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 7/14/2025)
| Balance Sheet | Total Assets | 2,812,200,000.00 | ROE | – |
| Balance Sheet | Total Equity | 1,473,100,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -2,800,000.00 | P/FCF | – |
| Cashflow | Free Cash Flow | 99,600,000.00 | – | – |
| Cashflow | Operating Cash Flow | 102,400,000.00 | P/CF | – |
| Income | Earnings per Share (diluted) | -0.01 | Div. Yield | – |
| Income | Net Income | -28,800,000.00 | P/E | – |
| Income | Shares Outstanding | 2,970,680,000.00 | P/B | – |
| Income | Total Revenue | 159,900,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.assuraplc.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more